In this context, the aim of this study is to investigate the role of MRF in endometrial cancer. Several applications are possible. Firstly, T1-, T2- and DWI-mappings can be associated to molecular risk group classification, in order to stratify patients' risk without recurring to surgery. MRF parameters can be also correlated to prognosis, both in terms of disease-free survival (DFS) and overall survival (OS).
Study Type
OBSERVATIONAL
Enrollment
150
Fondazione Policlinico Universitaro "A. Gemelli" IRCCS
Roma, Italy
RECRUITINGAssociation between T1-, T2- and diffusion-mappings and risk group classification
Time frame: 3 months
Diagnostic accuracy of T1-,T2- and diffusion-mappings deriving from MRF in myometrial invasion detection
Time frame: 3 months
Correlation between T1-, T2- and diffusion mappings and DFS and OS
Time frame: 3 years
Diagnostic accuracy of T1-,T2- and diffusion-mappings and pathological nodal involvement
Time frame: 3 months
Evaluation of Radiomic and Radiogenomic models to predict recurrence in early stage EC and to predict DFS and OS
Time frame: 3 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.